tm logo
ADRIEN GAGNON
Live/Registered
REGISTERED

on 17 Dec 2019

Last Applicant/ Owned by

3555 Matte Blvd., Door C

Brossard, Quebec

CA

J4Y2P4

Serial Number

88976227 filed on 03rd Jul 2018

Registration Number

5940312 registered on 17th Dec 2019

in the Principal Register

Correspondent Address

Joseph V. Myers III

JOSEPH V. MYERS III SEYFARTH SHAW LLP

ATLANTA, GA 30309

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ADRIEN GAGNON

Natural products for human use, namely, a formula composed of saw palmetto, pygeum, stinging nettle, white deadnettle, common heather and bearberry, all in the form of capsules for relieving benign prostate hyperplasia symptoms; collagen, in the form of tablets for relieving joint pain and symptoms related to arthritis and osteoarthritis and for contributing to the formation of healthy cartilage; Read More

Classification Information


Class [005]
Pharmaceutical Products


Natural products for human use, namely, a formula composed of saw palmetto, pygeum, stinging nettle, white deadnettle, common heather and bearberry, all in the form of capsules for relieving benign prostate hyperplasia symptoms; collagen, in the form of tablets for relieving joint pain and symptoms related to arthritis and osteoarthritis and for contributing to the formation of healthy cartilage; Natural products for human use, namely, capsules containing plant extracts to assist in weight loss; Natural products for human use, namely, plant and vitamin extracts in the form of ampoules and capsules for soothing respiratory symptoms due to a cold, flu, bronchitis and for increasing the bio-availability of Vitamin C by decreasing its elimination and oxidation; Natural products for human use, namely, plant extracts in the form of infusions, with purifying, eliminative, diuretic and laxative actions; Natural products for human use, namely, a supplement formula made of vitamins, plants and adaptogenic roots in the form of energizing ampoules, to increase resistance to stress and decrease the feeling of fatigue; Natural products for human use, namely, a supplement formula made of adaptogenic plants and roots in the form of energizing ampoules, to increase resistance to stress and decrease the feeling of fatigue, to decrease hyperglycemia and stimulate weakened immune systems and cognitive functions; Natural products for human use, namely, plant and root extracts in the form of capsules and ampoules to assist in slowing the advancement of benign prostate hypertrophy, controlling sleep disorders; a fatty acid and vitamin formula in the form of capsules for physical endurance, cholesterol level management and for the maintenance of good health; Natural products for human use, namely, plant extracts and antioxidant roots and fish oils in the form of capsules, gelcaps, liquids, to improve the cognitive functions of patients suffering from Alzheimer's or minor memory disorders, to contribute to the development and proper functioning of the brain; Natural products for human use, namely, type II collagen containing chondroitin and hyaluronic acid in the form of capsules for maintaining connective tissues, namely, joints and skin; Natural products for human use, namely, gel in the form of ampoules to combat fatigue


First Use Date in General

31st Oct 2016

First Use Date in Commerce

31st Oct 2016

Mark Details


Serial Number

No 88976227

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 105933000002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Dec 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17th Dec 2019REGISTERED-PRINCIPAL REGISTER
14th Nov 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
13th Nov 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12th Nov 2019STATEMENT OF USE PROCESSING COMPLETE
12th Nov 2019DIVISIONAL PROCESSING COMPLETE
12th Nov 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
29th Oct 2019USE AMENDMENT FILED
29th Oct 2019DIVISIONAL REQUEST RECEIVED
29th Oct 2019TEAS REQUEST TO DIVIDE RECEIVED